Skip to main content
Erschienen in: Neuroradiology 1/2005

01.01.2005 | Diagnostic Neuroradiology

Plasma vascular endothelial growth factor and serum soluble angiopoietin receptor sTIE-2 in patients with dural arteriovenous fistulas: a pilot study

verfasst von: Joachim Klisch, Ralf Kubalek, Kai M. Scheufler, Ute Zirrgiebel, Joachim Drevs, Martin Schumacher

Erschienen in: Neuroradiology | Ausgabe 1/2005

Einloggen, um Zugang zu erhalten

Abstract

Our aim was to correlate concentrations of circulating vascular endothelial growth factor (VEGF) and serum soluble angiopoietin receptor (sTIE-2) before and after endovascular treatment with the grading in human dural arteriovenous fistulas (DAVFs). In ten patients with DAVFs undergoing diagnostic cerebral angiography and endovascular intervention, pre-treatment and post-treatment levels of plasma VEGF and serum TIE-2 were examined in a prospective study design. A total of 32 plasma samples and 19 serum samples was collected from the cubital vein, the arterial sheath before and—if applicable—after intervention. Plasma VEGF and serum Tie-2 levels were measured by standardized ELISA protocols. In eight of ten patients with DAVF increased circulating VEGF levels (elevation of more than mean + 2 SD of published normal values) were found, whereas two patients showed increased sTIE-2 levels. Six of the seven patients treated by endovascular embolization displayed a post-interventional decrease of VEGF values. The serum TIE-2 levels decreased slightly after intervention. Pre-treatment vVEGF levels varied significantly between patients with grades I and II/III fistulas according to the Cognards classification system. Our pilot study suggests that assessment of angiogenesis parameters in patients with DAVFs might correlate with the DAVFs’ grade. To support the hypothesis that a change in angiogenic indicators may serve as indicators for a response to therapy, a larger number of patients should be followed for a longer time period.
Literatur
1.
Zurück zum Zitat Harrigan MR (2003) Angiogenic factors in the central nervous system. Neurosurgery 53:639–660CrossRef Harrigan MR (2003) Angiogenic factors in the central nervous system. Neurosurgery 53:639–660CrossRef
2.
Zurück zum Zitat Lasjaunias P, Chiu M, terBrugge K, Tolia A, Hurth M, Berenstein A (1986) Neurological manifestations of intracranial dural arteriovenous malformations. J Neurosurg 64:724–730 Lasjaunias P, Chiu M, terBrugge K, Tolia A, Hurth M, Berenstein A (1986) Neurological manifestations of intracranial dural arteriovenous malformations. J Neurosurg 64:724–730
3.
Zurück zum Zitat Kutluk K, Schumacher M, Mironov A (1991) The role of sinus thrombosis in occipital dural arteriovenous malformations—development and spontaneous closure. Neurochirurgia (Stuttg) 34:144–147 Kutluk K, Schumacher M, Mironov A (1991) The role of sinus thrombosis in occipital dural arteriovenous malformations—development and spontaneous closure. Neurochirurgia (Stuttg) 34:144–147
4.
Zurück zum Zitat Lawton MT, Jacobowitz R, Spetzler RF (1997) Redifined role of angiogenesis in the pathogenesis of dural arteriovenous malformations. J Neurosurg 87:267–274 Lawton MT, Jacobowitz R, Spetzler RF (1997) Redifined role of angiogenesis in the pathogenesis of dural arteriovenous malformations. J Neurosurg 87:267–274
5.
Zurück zum Zitat Dudeck O, van Velthoven V, Schumacher M, Klisch J (2004) De novo development of a complex dural arteriovenous fistula next to a cerebellar developmental venous anomaly after resection of a brainstem cavernoma. Case report and review of the literature. J Neurosurg 100:335–339 Dudeck O, van Velthoven V, Schumacher M, Klisch J (2004) De novo development of a complex dural arteriovenous fistula next to a cerebellar developmental venous anomaly after resection of a brainstem cavernoma. Case report and review of the literature. J Neurosurg 100:335–339
6.
Zurück zum Zitat Friedman JA, Meyer FB, Nichols DA, Coffey RJ, Hopkins LN, Maher CO, Meissner ID, Pollock BE (2001) Fatal progression of posttraumatic dural arteriovenous fistulas refractory to multimodal therapy. Case report. J Neurosurg 94:831–835 Friedman JA, Meyer FB, Nichols DA, Coffey RJ, Hopkins LN, Maher CO, Meissner ID, Pollock BE (2001) Fatal progression of posttraumatic dural arteriovenous fistulas refractory to multimodal therapy. Case report. J Neurosurg 94:831–835
7.
Zurück zum Zitat Hamada Y, Goto K, Inoue T, Iwaki T, Matsuno H, Suzuki S, Matsushima T, Fukui M, Miyake E (1997) Histopathologic aspects of dural arteriovenous fistulas in the transverse–sigmoid sinus region in nine patients. Neurosurgery 40:452–456CrossRef Hamada Y, Goto K, Inoue T, Iwaki T, Matsuno H, Suzuki S, Matsushima T, Fukui M, Miyake E (1997) Histopathologic aspects of dural arteriovenous fistulas in the transverse–sigmoid sinus region in nine patients. Neurosurgery 40:452–456CrossRef
8.
Zurück zum Zitat Nishijima M, Takaku A, Endo S, Kuwayama N, Koizumi F, Sato H, Owada K (1992) Etiologic evaluation of dural arteriovenous malformations of the lateral and sigmoid sinuses based on histopathological examinations. J Neurosurg 76:600–606 Nishijima M, Takaku A, Endo S, Kuwayama N, Koizumi F, Sato H, Owada K (1992) Etiologic evaluation of dural arteriovenous malformations of the lateral and sigmoid sinuses based on histopathological examinations. J Neurosurg 76:600–606
9.
Zurück zum Zitat Sure U, Butz N, Schlegel J, Siegel AM, Wakat JP, Mennel HD, Bien S, Bertalanffy H (2001) Endothelial proliferation, neoangiogenesis, and potential de novo generation of cerebrovascular malformations. J Neurosurg 94:972–977PubMed Sure U, Butz N, Schlegel J, Siegel AM, Wakat JP, Mennel HD, Bien S, Bertalanffy H (2001) Endothelial proliferation, neoangiogenesis, and potential de novo generation of cerebrovascular malformations. J Neurosurg 94:972–977PubMed
10.
Zurück zum Zitat Terada T, Tsuura M, Komai N, Higashida RT, Halbach VV, Dowd C, Hieshima GB (1996) The role of angiogenic factor bFGF in the development of AVFs. Acta Neurochir (Wien) 138:877–883 Terada T, Tsuura M, Komai N, Higashida RT, Halbach VV, Dowd C, Hieshima GB (1996) The role of angiogenic factor bFGF in the development of AVFs. Acta Neurochir (Wien) 138:877–883
11.
Zurück zum Zitat Uranishi R, Nakase H, Sakaki T (1999) Expression of angiogenic growth factors in dural arteriovenous fistula. J Neurosurg 91:781–786 Uranishi R, Nakase H, Sakaki T (1999) Expression of angiogenic growth factors in dural arteriovenous fistula. J Neurosurg 91:781–786
12.
Zurück zum Zitat Chin KF, Greenman J, Reusch P, Gardiner E, Marme D, Monson JR (2003) Vascular endothelial growth factor and soluble Tie-2 receptor in colorectal cancer: associations with disease recurrence. Eur J Surg Oncol 29:497–505CrossRef Chin KF, Greenman J, Reusch P, Gardiner E, Marme D, Monson JR (2003) Vascular endothelial growth factor and soluble Tie-2 receptor in colorectal cancer: associations with disease recurrence. Eur J Surg Oncol 29:497–505CrossRef
13.
Zurück zum Zitat Scheufler KM, Drevs J, Van Velthoven V, Reusch P, Klisch J, Augustin HG, Zentner J, Marme D (2003) Implications of vascular endothelial growth factor, sFlt-1, and sTie-2 in plasma, serum and cerebrospinal fluid during cerebral ischemia in man. J Cereb Blood Flow Metab 23:99–110CrossRef Scheufler KM, Drevs J, Van Velthoven V, Reusch P, Klisch J, Augustin HG, Zentner J, Marme D (2003) Implications of vascular endothelial growth factor, sFlt-1, and sTie-2 in plasma, serum and cerebrospinal fluid during cerebral ischemia in man. J Cereb Blood Flow Metab 23:99–110CrossRef
14.
Zurück zum Zitat Lee JK, Hong YJ, Han CJ, Hwang DY, Hong SI (2000) Clinical usefulness of serum and plasma vascular endothelial growth factor in cancer patients: which is the optimal specimen? Int J Oncol 17:149–152 Lee JK, Hong YJ, Han CJ, Hwang DY, Hong SI (2000) Clinical usefulness of serum and plasma vascular endothelial growth factor in cancer patients: which is the optimal specimen? Int J Oncol 17:149–152
15.
Zurück zum Zitat Webb NJ, Bottomley MJ, Watson CJ, Brenchley PE (1998) Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease. Clin Sci (Lond) 94:395–404 Webb NJ, Bottomley MJ, Watson CJ, Brenchley PE (1998) Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease. Clin Sci (Lond) 94:395–404
16.
Zurück zum Zitat Awad IA, Little JR, Akarawi WP, Ahl J (1990) Intracranial dural arteriovenous malformations: factors predisposing to an aggressive neurological course. J Neurosurg 72:839–850 Awad IA, Little JR, Akarawi WP, Ahl J (1990) Intracranial dural arteriovenous malformations: factors predisposing to an aggressive neurological course. J Neurosurg 72:839–850
17.
Zurück zum Zitat Klisch J, Huppertz HJ, Spetzger U, Hetzel A, Seeger W, Schumacher M (2003) Transvenous treatment of carotid cavernous and dural arteriovenous malformations: results in 31 patients with review of the literature. Neurosurgery 53:836–856CrossRef Klisch J, Huppertz HJ, Spetzger U, Hetzel A, Seeger W, Schumacher M (2003) Transvenous treatment of carotid cavernous and dural arteriovenous malformations: results in 31 patients with review of the literature. Neurosurgery 53:836–856CrossRef
18.
Zurück zum Zitat Chaloupka JC, Huddle DC, Aldermann J (1999) Local induction of angiogenesis within the walls of a dural sinus results in the creation of dural arteriovenous fistula. Demonstration by polymeric release implantation model in swine. J Neurosurg 90:194A Chaloupka JC, Huddle DC, Aldermann J (1999) Local induction of angiogenesis within the walls of a dural sinus results in the creation of dural arteriovenous fistula. Demonstration by polymeric release implantation model in swine. J Neurosurg 90:194A
19.
Zurück zum Zitat Cognard C, Gobin YP, Pierot L, Bailly AL, Houdart E, Casasco A, Chiras J, Merland JJ (1995) Cerebral dural arteriovenous fistulas: clinical and angiographic correlation with a revised classification of venous drainage. Radiology 194:671–680 Cognard C, Gobin YP, Pierot L, Bailly AL, Houdart E, Casasco A, Chiras J, Merland JJ (1995) Cerebral dural arteriovenous fistulas: clinical and angiographic correlation with a revised classification of venous drainage. Radiology 194:671–680
20.
Zurück zum Zitat Slevin M, Krupinski J, Slowik A, Rubio F, Szczudlik A, Gaffney J (2000) Activation of MAP kinase (ERK-1/ERK-2), tyrosine kinase and VEGF in the human brain following acute ischaemic stroke. Neuroreport 11:2759–2764 Slevin M, Krupinski J, Slowik A, Rubio F, Szczudlik A, Gaffney J (2000) Activation of MAP kinase (ERK-1/ERK-2), tyrosine kinase and VEGF in the human brain following acute ischaemic stroke. Neuroreport 11:2759–2764
21.
Zurück zum Zitat Suzuki R, Fukai N, Nagashijma G, Asai JI, Itokawa H, Nagai M, Suzuki T, Fujimoto T (2003) Very early expression of vascular endothelial growth factor in brain oedema tissue associated with brain contusion. Acta Neurochir Suppl 86:277–279 Suzuki R, Fukai N, Nagashijma G, Asai JI, Itokawa H, Nagai M, Suzuki T, Fujimoto T (2003) Very early expression of vascular endothelial growth factor in brain oedema tissue associated with brain contusion. Acta Neurochir Suppl 86:277–279
22.
Zurück zum Zitat Herman JM, Spetzler RF, Bederson JB, Kurbat JM, Zabramski JM (1995) Genesis of a dural arteriovenous malformation in a rat model. J Neurosurg 83:539–545 Herman JM, Spetzler RF, Bederson JB, Kurbat JM, Zabramski JM (1995) Genesis of a dural arteriovenous malformation in a rat model. J Neurosurg 83:539–545
23.
Zurück zum Zitat Gunsilius E, Petzer AL, Stockhammer G, Kahler CM, Gastl G (2001) Serial measurement of vascular endothelial growth factor and transforming growth factor-beta1 in serum of patients with acute ischemic stroke. Stroke 32:275–278 Gunsilius E, Petzer AL, Stockhammer G, Kahler CM, Gastl G (2001) Serial measurement of vascular endothelial growth factor and transforming growth factor-beta1 in serum of patients with acute ischemic stroke. Stroke 32:275–278
24.
Zurück zum Zitat Salgado R, Benoy I, Bogers J, Weytjens R, Vermeulen P, Dirix L, Van Marck E (2001) Platelets and vascular endothelial growth factor (VEGF): a morphological and functional study. Angiogenesis 4:37–43CrossRef Salgado R, Benoy I, Bogers J, Weytjens R, Vermeulen P, Dirix L, Van Marck E (2001) Platelets and vascular endothelial growth factor (VEGF): a morphological and functional study. Angiogenesis 4:37–43CrossRef
25.
Zurück zum Zitat Kraiss LW, Geary RL, Mattsson EJ, Vergel S, Au YP, Clowes AW (1996) Acute reductions in blood flow and shear stress induce platelet-derived growth factor-A expression in baboon prosthetic grafts. Circ Res 79:45–53 Kraiss LW, Geary RL, Mattsson EJ, Vergel S, Au YP, Clowes AW (1996) Acute reductions in blood flow and shear stress induce platelet-derived growth factor-A expression in baboon prosthetic grafts. Circ Res 79:45–53
26.
Zurück zum Zitat Caunt M, Huang YQ, Brooks PC, Karpatkin S (2003) Thrombin induces neoangiogenesis in the chick chorioallantoic membrane. J Thromb Haemost 1:2097–2102CrossRef Caunt M, Huang YQ, Brooks PC, Karpatkin S (2003) Thrombin induces neoangiogenesis in the chick chorioallantoic membrane. J Thromb Haemost 1:2097–2102CrossRef
27.
Zurück zum Zitat Kim I, Kim HG, Moon SO, Chae SW, So JN, Koh KN, Ahn BC, Koh GY (2000) Angiopoietin-1 induces endothelial cell sprouting through the activation of focal adhesion kinase and plasmin secretion. Circ Res 86:952–959 Kim I, Kim HG, Moon SO, Chae SW, So JN, Koh KN, Ahn BC, Koh GY (2000) Angiopoietin-1 induces endothelial cell sprouting through the activation of focal adhesion kinase and plasmin secretion. Circ Res 86:952–959
28.
Zurück zum Zitat Kim I, Kim JH, Moon SO, Kwak HJ, Kim NG, Koh GY (2000) Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Oncogene 19:4549–4552CrossRef Kim I, Kim JH, Moon SO, Kwak HJ, Kim NG, Koh GY (2000) Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Oncogene 19:4549–4552CrossRef
29.
Zurück zum Zitat Nourhaghighi N, Teichert-Kuliszewska K, Davis J, Stewart DJ, Nag S (2003) Altered expression of angiopoietins during blood–brain barrier breakdown and angiogenesis. Lab Invest 83:1211–1222CrossRef Nourhaghighi N, Teichert-Kuliszewska K, Davis J, Stewart DJ, Nag S (2003) Altered expression of angiopoietins during blood–brain barrier breakdown and angiogenesis. Lab Invest 83:1211–1222CrossRef
30.
Zurück zum Zitat Sato A, Iwama A, Takakura N, Nishio H, Yancopoulos GD, Suda T (1998) Characterization of TEK receptor tyrosine kinase and its ligands, angiopoietins, in human hematopoietic progenitor cells. Int Immunol 10:1217–1227CrossRef Sato A, Iwama A, Takakura N, Nishio H, Yancopoulos GD, Suda T (1998) Characterization of TEK receptor tyrosine kinase and its ligands, angiopoietins, in human hematopoietic progenitor cells. Int Immunol 10:1217–1227CrossRef
31.
Zurück zum Zitat Takakura N, Huang XL, Naruse T, Hamaguchi I, Dumont DJ, Yancopoulos GD, Suda T (1998) Critical role of the TIE2 endothelial cell receptor in the development of definitive hematopoiesis. Immunity 9:677–686CrossRef Takakura N, Huang XL, Naruse T, Hamaguchi I, Dumont DJ, Yancopoulos GD, Suda T (1998) Critical role of the TIE2 endothelial cell receptor in the development of definitive hematopoiesis. Immunity 9:677–686CrossRef
32.
Zurück zum Zitat Teichert-Kuliszewska K, Maisonpierre PC, Jones N, Campbell AI, Master Z, Bendeck MP, Alitalo K, Dumont DJ, Yancopoulos GD, Stewart DJ (2001) Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2. Cardiovasc Res 49:659–670CrossRef Teichert-Kuliszewska K, Maisonpierre PC, Jones N, Campbell AI, Master Z, Bendeck MP, Alitalo K, Dumont DJ, Yancopoulos GD, Stewart DJ (2001) Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2. Cardiovasc Res 49:659–670CrossRef
33.
Zurück zum Zitat Zirrgiebel U, Drevs J (2003) Surrogate marker in clinical studies with anti-angiogenic drugs. Int J Clin Pharmacol Ther 41:600–602 Zirrgiebel U, Drevs J (2003) Surrogate marker in clinical studies with anti-angiogenic drugs. Int J Clin Pharmacol Ther 41:600–602
Metadaten
Titel
Plasma vascular endothelial growth factor and serum soluble angiopoietin receptor sTIE-2 in patients with dural arteriovenous fistulas: a pilot study
verfasst von
Joachim Klisch
Ralf Kubalek
Kai M. Scheufler
Ute Zirrgiebel
Joachim Drevs
Martin Schumacher
Publikationsdatum
01.01.2005
Erschienen in
Neuroradiology / Ausgabe 1/2005
Print ISSN: 0028-3940
Elektronische ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-004-1310-3

Weitere Artikel der Ausgabe 1/2005

Neuroradiology 1/2005 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Neu im Fachgebiet Neurologie

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.